The Diverticular Disease Market segment is fundamentally structured around three major components: Diagnosis, Treatment, and End-User. The Diagnosis segment includes Imaging (CT, MRI, Ultrasound) and Endoscopy (Colonoscopy), with CT-related services driving significant value in acute care. The Treatment segment is crucial, segmented into Pharmaceuticals (Antibiotics, Mesalazine, Rifaximin, Analgesics) and Surgical Intervention (Elective and Emergency Colectomy). The Pharmaceutical segment holds the largest volume, but the surgical segment commands the highest value per procedure due to device and hospital costs.

The Surgical Intervention segment is further segmented by technique (Laparoscopic/Robotic vs. Open Surgery), with minimally invasive techniques driving demand for high-cost advanced devices. End-user segmentation includes Hospitals (dominating acute care and surgery), and Specialized Clinics & Retail Pharmacies (dominating chronic pharmaceutical sales). The market structure is defined by the high-value of acute hospital-based interventions contrasted with the vast volume of low-cost chronic pharmaceutical and supplement sales required for lifelong management.